These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27278335)

  • 21. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathology and DNA cytophotometry of small hepatocellular carcinoma with a nodule-in-nodule appearance--evidence for stepwise progression of hepatocellular carcinoma.
    Rim KS; Sakamoto M; Watanabe H; Matsuno Y; Nakanishi Y; Mukai K; Hirohashi S
    Jpn J Clin Oncol; 1993 Feb; 23(1):26-33. PubMed ID: 8384672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
    Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
    Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newly developed hypervascular hepatocellular carcinoma during follow-up periods in patients with chronic liver disease: observation in serial gadoxetic acid-enhanced MRI.
    Yamamoto A; Ito K; Tamada T; Higaki A; Kanki A; Sato T; Tanimoto D
    AJR Am J Roentgenol; 2013 Jun; 200(6):1254-60. PubMed ID: 23701061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
    Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
    J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma.
    Numata K; Fukuda H; Miwa H; Ishii T; Moriya S; Kondo M; Nozaki A; Morimoto M; Okada M; Takebayashi S; Maeda S; Nozawa A; Nakano M; Tanaka K
    Eur J Radiol; 2014 Jan; 83(1):95-102. PubMed ID: 24176532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of hepatocellular carcinoma which could be diagnosed with Gd-EOB-DTPA enhanced MRI].
    Ota H; Mikami K; Nagase A; Nagase H; Mukai R; Okada K; Ide Y; Maruyama K; Murata K; Yokouchi H; Tamai M; Kinuta M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2386-8. PubMed ID: 20037431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.
    Korkusuz H; Knau LL; Kromen W; Bihrer V; Keese D; Piiper A; Vogl TJ
    J Magn Reson Imaging; 2012 Jun; 35(6):1397-402. PubMed ID: 22267126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas--correlation with histological differentiation.
    Strobel D; Kleinecke C; Hänsler J; Frieser M; Händl T; Hahn EG; Bernatik T
    Ultraschall Med; 2005 Aug; 26(4):270-6. PubMed ID: 16123920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early stage hepatocellular carcinoma detected during intraoperative ultrasonography.
    Eguchi A; Furuta T; Haraguchi M; Sugimachi K
    Am J Gastroenterol; 1994 Apr; 89(4):595-8. PubMed ID: 8147364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT.
    Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Chung H; Kawasaki T; Maekawa K
    Radiology; 2001 Dec; 221(3):721-30. PubMed ID: 11719668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging.
    Sano K; Ichikawa T; Motosugi U; Sou H; Muhi AM; Matsuda M; Nakano M; Sakamoto M; Nakazawa T; Asakawa M; Fujii H; Kitamura T; Enomoto N; Araki T
    Radiology; 2011 Dec; 261(3):834-44. PubMed ID: 21998047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.
    Maruyama H; Takahashi M; Ishibashi H; Okabe S; Yoshikawa M; Yokosuka O
    Eur J Radiol; 2010 Jul; 75(1):e102-6. PubMed ID: 19783392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathological diagnosis of early HCC through biopsy: efficacy of Victoria blue and cytokeratin 7 staining.
    Kobayashi S; Kim SR; Imoto S; Ando K; Hirakawa M; Saito J; Fukuda K; Otono Y; Sakaki M; Tsuchida S; Kim SK; Hayashi Y; Nakano M; Kudo M
    Dig Dis; 2012; 30(6):574-9. PubMed ID: 23258097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma not detected with plain US: treatment with percutaneous ethanol injection under guidance with enhanced US.
    Imari Y; Sakamoto S; Shiomichi S; Isobe H; Ikeda M; Satoh M; Nawata H
    Radiology; 1992 Nov; 185(2):497-500. PubMed ID: 1329144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HCC-to-liver contrast on arterial-dominant phase images of EOB-enhanced MRI: comparison with dynamic CT.
    Kanata N; Yoshikawa T; Ohno Y; Kanda T; Uchida K; Izaki K; Fukumoto T; Ku Y; Itoh T; Kitajima K; Takahashi S; Sugimura K
    Magn Reson Imaging; 2013 Jan; 31(1):17-22. PubMed ID: 22898685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic ct and a combination of CT and angiography: experience with resected liver specimens.
    Takayasu K; Muramatsu Y; Mizuguchi Y; Moriyama N; Ojima H
    Intervirology; 2004; 47(3-5):199-208. PubMed ID: 15383730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic imaging of hepatocellular carcinoma: recent progress.
    Kudo M
    Oncology; 2011; 81 Suppl 1():73-85. PubMed ID: 22212940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.
    Forner A; Vilana R; Bianchi L; Rodríguez-Lope C; Reig M; García-Criado MÁ; Rimola J; Solé M; Ayuso C; Bru C; Bruix J
    J Hepatol; 2015 Jan; 62(1):150-5. PubMed ID: 25173969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
    Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
    J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.